市场调查报告书
商品编码
1603340
药品物流市场规模、份额、按类型、组成部分、运输方式和地区分類的成长分析 - 产业预测,2024-2031 年Pharmaceutical Logistics Market Size, Share, Growth Analysis, By Type (Cold chain logistics, non-cold chain logistics), By Component (Storage, transportation, monitoring), By Mode of Transportation (Air, Sea), By Region - Industry Forecast 2024-2031 |
2022年全球医药物流市场规模将为779.7亿美元,从2023年的852.4亿美元成长到2031年的1,701.7亿美元,复合年增长率预计将成长9.2%。
由于生物生物製药需求不断增长以及慢性病患病率上升,目标患者群体不断扩大,预计医药物流市场将显着增长。随着医疗保健的发展,合规性变得至关重要,要求在整个供应链中运输、储存和处理药品时格外小心。为了打击假药,人们越来越关注产品检验和安全性,从而推动了对温度控制和低温运输储存等专业服务的需求。此外,使用航空货运远距运输昂贵的疫苗和药品的转变将提高物流效率。随着非处方药消费量的急剧增加以及医疗保健部门对援助的迅速接受,市场正在蓄势待发。政府支持医疗物流的倡议预计也将创造重大成长机会。在这些因素的综合作用下,医药物流市场正进入强劲扩张阶段。相关人员正在努力建立弹性系统,以便在世界各地及时、安全地提供基本药物。
Global Pharmaceutical Logistics Market size was valued at USD 77.97 billion in 2022 and is poised to grow from USD 85.24 billion in 2023 to USD 170.17 billion by 2031, growing at a CAGR of 9.2% in the forecast period (2024-2031).
The pharmaceutical logistics market is poised for considerable growth, driven by the increasing demand for biological drugs and the rising prevalence of chronic diseases, which is expanding the target patient population. As healthcare evolves, regulatory compliance becomes paramount, necessitating meticulous transport, storage, and handling of pharmaceutical products throughout the supply chain. The heightened focus on product verification and safety is becoming increasingly important to combat counterfeit drugs, and there is a growing demand for specialized services like temperature-controlled and cold chain storage. Furthermore, the shift towards utilizing air freight for the long-distance distribution of high-value vaccines and medications is set to enhance logistical efficiency. Coupled with a surge in the consumption of over-the-counter medications and the healthcare sector's embrace of fast-track assistance, the market is gaining momentum. Government initiatives designed to support healthcare logistics are also expected to create substantial growth opportunities. With the convergence of these factors, the pharmaceutical logistics market is entering a phase of robust expansion, as stakeholders look to build resilient systems that ensure timely and safe delivery of essential pharmaceutical products worldwide.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Logistics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Logistics Market Segmental Analysis
Global Pharmaceutical Logistics Market is segmented by Type, by Component, by Mode of Transportation, by Application and by Region. Based on Type, the market is segmented into Cold chain logistics, and non-cold chain logistics. Based on Component, the market is segmented into Transportation, Storage, and Monitoring. Based on Mode of Transportation, the market is segmented into Air, Sea, Road, Rail. Based on Application, the market is segmented into Bio Pharma, Chemical Pharma, and Speciality Pharma. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Pharmaceutical Logistics Market
The Global Pharmaceutical Logistics market is significantly influenced by the necessity to preserve cold chain integrity for pharmaceutical products while simultaneously reducing distribution costs through streamlined, single-source distribution channels. This demand is further propelled by the rising need for pharmaceuticals, which is closely tied to the increase in global life expectancy over recent years. As life expectancy continues to rise, global pharmaceutical sales are anticipated to grow, encouraging end-user sectors to adopt robust cold chain logistics solutions. This trend underscores the pharmaceutical industry's escalating requirement for efficient logistics to keep pace with heightened demand and ensure product integrity throughout the supply chain.
Restraints in the Global Pharmaceutical Logistics Market
The growth of the global pharmaceutical logistics market may be hindered by the need for well-coordinated and interconnected logistics services that ensure high levels of confidentiality throughout the pharmaceutical supply chain. Additionally, inefficiencies in various logistics products, along with inconsistent pricing policies that vary by region, present significant challenges to market expansion. As these factors create complexities within the industry, they may restrict the efficiency and effectiveness of pharmaceutical logistics, ultimately stalling growth in an increasingly globalized marketplace. Consequently, addressing these restraints is essential for fostering a more robust pharmaceutical logistics environment.
Market Trends of the Global Pharmaceutical Logistics Market
The Global Pharmaceutical Logistics market is witnessing significant growth driven by an increasing focus on stringent compliance with GDP guidelines and advanced tracking technologies such as GPS and remote temperature monitoring. This trend is paramount in ensuring the safe transportation and delivery of pharmaceuticals, particularly high-value products like narcotics and temperature-sensitive medications. Moreover, the industry faces challenges such as complex regulatory landscapes, diverse product offerings, and the need for specialized delivery patterns tailored to various pharmaceutical categories. Additionally, concerns regarding counterfeit products and the shipment of R&D products for clinical trials are reshaping logistics strategies, prompting investment in third-party logistics solutions to enhance efficiency and reliability.